Dynarex Recalls Wecare Calasoothe Ointment Over cGMP Violations
Dynarex Corporation recalled 2,400 containers of Wecare Calasoothe on October 31, 2025, due to cGMP deviations. The recall affects the 4 oz ointment, as it may not meet safety standards. Consumers should stop using the product immediately and consult their healthcare providers.
About This Product
Wecare Calasoothe is a topical ointment containing menthol and zinc oxide. Consumers typically use it for soothing skin irritations and minor wounds.
Why This Is Dangerous
The cGMP deviations may affect the product's quality and safety, potentially leading to ineffective treatment or adverse reactions.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers may face safety risks by using this product. Immediate action is necessary to prevent potential health issues.
Practical Guidance
How to identify if yours is affected
- Check the lot number on your product packaging.
- Verify if your product is Lot #: A482305.
- Stop using the product immediately if it matches the lot number.
Where to find product info
Lot numbers can typically be found on the bottom or side of the container.
What timeline to expect
Expect processing for refunds or replacements to take approximately 4-6 weeks.
If the manufacturer is unresponsive
- Document your communication attempts with the company.
- Consider reaching out to consumer protection agencies for assistance.
- Check back for updates from the manufacturer regarding the recall.
How to prevent similar issues
- Look for products with current Good Manufacturing Practice certifications.
- Verify the manufacturer's reputation before purchase.
- Research product reviews to ensure safety and effectiveness.
Documentation advice
Keep copies of receipts, photographs of the product, and any communications with the manufacturer.